paeonol has been researched along with potassium chloride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, YX; Li, YK; Weng, WL; Zhang, JY; Zhao, L | 1 |
| Bai, TT; Cao, HL; Chen, YL; He, CX; Li, AH; Li, HJ; Li, L; Li, PQ; Liu, JL; Liu, YX; Qin, W; Su, XL; Wang, JK; Wang, M; Wu, SP; Xing, L; Zhao, D; Zhou, X | 1 |
2 other study(ies) available for paeonol and potassium chloride
| Article | Year |
|---|---|
Paeonol induces vasodilatation in rat mesenteric artery via inhibiting extracellular Ca²⁺ influx and intracellular Ca²⁺ release.
Topics: Acetophenones; Adrenergic beta-Antagonists; Animals; Calcium; Calcium Chloride; Endothelium, Vascular; Extracellular Space; Female; In Vitro Techniques; Intracellular Space; Male; Mesenteric Arteries; Norepinephrine; Potassium Channel Blockers; Potassium Chloride; Rats; Rats, Sprague-Dawley; Serotonin; Vasoconstriction; Vasodilation | 2013 |
New paeonol derivative C302 reduces hypertension in spontaneously hypertensive rats through endothelium-dependent and endothelium-independent vasodilation.
Topics: Acetophenones; Animals; Antihypertensive Agents; Endothelium, Vascular; Hypertension; Potassium Chloride; Rats; Rats, Inbred SHR; Vasodilation | 2022 |